Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Learn More

 

Privileged Access to GI Immunology and Convergent Pathways

Learn More

Changing the Paradigm for Biologics
 

Learn More

News:

Jun 
09, 
2020

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares | Learn More

Events:

No events scheduled at this time.